Dhaliwal Harpreet S. 4

What Happened
Harpreet S. Dhaliwal, Chief Technical Operations Officer of Vaxcyte (PCVX), surrendered 604 shares of common stock on March 9, 2026 to cover tax withholding obligations tied to vested restricted stock units (RSUs). The shares were recorded at $59.32 each, totaling approximately $35,829. This was a tax-withholding share surrender (not an open-market sale).

Key Details

• Transaction date: March 9, 2026; filing date: March 11, 2026 (timely filing).
• Shares surrendered/disposed: 604 at $59.32 per share; total value ≈ $35,829.
• Transaction code: F (payment of exercise price or tax liability via share surrender).
• Shares owned after transaction: not specified in this Form 4.
• Footnote: The 604 shares were surrendered to the issuer specifically to cover tax withholding on RSU vesting; no other shares subject to the January 29, 2026 lock-up were sold.

Context
Surrendering shares to cover taxes after RSU vesting is a routine, administrative transaction and does not by itself indicate insider sentiment about the stock. This was a cashless/share-surrender withholding method rather than an open-market sale or purchase.